Exemestane 25mg

Exemestane 25mg

Product Overview

Generic NameExemestane 25mg
Brand Name(s)AROMASIN®, Nodutax, Xenq
CategoryAntineoplastic / Cancer
Form30 Oral tablet
Strength25 mg
Therapeutic ClassAromatase inhibitor
ATC CodeL02BG06

Manufacturing & Regulatory

ManufacturerPfizer, Sun Pharmaceutical Ltd
GMP ComplianceWHO-GMP
COFEPRIS010.000.5418.02
Free Sale CertificateAvailable per batch upon request

Logistics & Export

MOQ10 Units
Shelf Life36 months
StorageStore = 25 °C, protect from light
IncotermsEXW 30049049
Lead Time7 - 10 Business Days

Documentation Available Upon Request

Certificate of Analysis (PDF)Supplied per batch upon request

Special Notes

Exemestane is an aromatase inhibitor used for hormone-receptor-positive breast cancer in postmenopausal women, including (i) adjuvant treatment after 2–3 years of tamoxifen to complete 5 years of endocrine therapy, and (ii) advanced breast cancer progressing after tamoxifen. Standard dose in labeling is 25 mg once daily after a meal